DALLAS, Texas—RTKL was selected to design a proton therapy facility in Irving, Texas. Baylor Health Enterprises recently announced that the Irving-Las Colinas area was chosen as the site for the $105-million innovative proton therapy facility to serve the Dallas-Fort Worth metroplex. Construction is expected to begin on the new 50,000-square-footIrving facility in the spring of 2013, with an opening date set for late 2015.
The new facility will house the most advanced features and capabilities for cancer treatment. It will include a proton cyclotron, two isocentric-gantry treatment rooms, a fixed-beam treatment room and advanced image guidance technology. Such technology enables proton therapy to focus radiation precisely to very small parts of the body, an approach that has been effective in treating certain pediatric and adult cancers, including tumors in the brain, head and neck, lung and prostate.
The facility will provide services through Texas Oncology and will afford patients the opportunity to participate in advanced clinical trials in partnership with the US Oncology Network. Texas Oncology is a member of The US Oncology Network, which includes privately held community-based oncology practices across the country that may also refer patients to the facility.
